Digest Network Come funziona
Digest / Comunicato

Compatibilità
Salva()
Condividi
Recapiti
Vuoi vedere nel tuo digest i prossimi comunicati di questo professionista?

Comunicati correlati

24/04/2025
Farmaceutica
Sanità
Biologia
IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2- Breast Cancer Treatment Landscape | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
Scopri affinità
0
Press Release cover image
14/10/2024
Farmaceutica
Sanità
Biologia
CDK4/6 Inhibitors Market to Grow at Healthy Growth Rate by 2034 Owing to Expanded Usage of Approved Blockbuster CDK4/6 Inhibitors in Early-stage Breast Cancer and the Emergence of Newer Players in Other Indications | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
Scopri affinità
0
26/02/2025
Scienza
Medicina - Varie
Salute
Vetrine/Shopping
Farmaceutica
Sanità
Oncologia
Industria
Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
Fonte
AstraZeneca
Emittente
Business Wire
Scopri affinità
0